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Background: The advantage of a pancreaticogastrostomy (PG) over a pancreaticojejunostomy (PJ) after
a pancreaticoduodenectomy (PD) is not clear.
Aim: The aim of the present study was to compare the pancreatic fistula (PF, defined according to the
International Study Group for Pancreatic Fistula classification) rate and other complications between both
methods.
Methods: Retrospective analysis of prospectively collected data of 424 [median: 65 years (17–83)]
patients who underwent PG (239, 56.4%) and PJ (185, 43.6%) reconstruction between January 2005 and
December 2009.
Results: PF occurred in 55 (23.5%) in the PG and 30 (16.2%, P = 0.067) patients in the PJ group. Grade
A PF occurred in 19 (7.9%), B in 22 (9.2%) and C in 14 (5.8%) in the PG compared with 5 (2.7%), 12 (6.5%)
and in 13 (7.0%), respectively, in the PJ group. The median hospital was 10 days in both groups. The
morbidity was higher in the PG group (108, 45.2 vs. 62, 33.5%, P = 0.015). However, there was no
significant difference in the 90-day mortality between both groups (PG-17, 7.0% vs. PJ-16, 8.6%,
P = 0.558).
Conclusion: There was no difference in the overall PF rate, hospital stay and overall mortality between
PG and PJ reconstruction methods. However, the grade A PF rate was higher in the PG group.
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Introduction
A pancreaticoduodenectomy (PD) is the only available curative
treatment option for patients with pancreatic head and peri-
ampullary malignancy. However, PD is associated with significant
morbidity and mortality mainly as a result of leakage from pan-
creatic anastomosis (pancreatic fistula, PF). The rate of PF is
highly variable, ranging from 2% to 30%1–9 depending on the type
of definition used. A pancreaticojejunostomy (PJ) is the most
commonly used reconstructive method after PD and several alter-
native techniques and of variations of PJ have been described to
reduce the PF rate. A pancreaticogastrostomy (PG) is the most
widely used alternative reconstructive method. However, the
advantage or disadvantages of PG over PJ is not clear.10–20 Evidence
from several non-randomized studies suggests that the morbidity
and mortality secondary to PF after PG is much less compared
with PJ anastomosis. Contrarily, the evidence from randomized
controlled studies suggests that there was no difference between
both methods.
The major criticism of the previously published studies was
that there were wide variations in the definition of PF precluding
accurate comparison of the results. To allow the comparison of
various techniques and results from various centres, an
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International Study group for Grading of Pancreatic Fistula
(ISGPF) has developed a classification system for the grading of
PF based on both clinical and biochemical parameters.21 Since its
publication in 2005, there were no major studies which studied
the rate of PF (graded according to the ISGPF system) and asso-
ciated complications between PG and PJ methods after PD. The
aim of the present study was to examine the rate of PF and asso-
ciated morbidity and mortality in a large group of patients who
underwent PG and PJ reconstruction after PD.
Material and methods
Between January 2005 and December 2009, retrospective analysis
was undertaken of all prospectively collected data of all patients
who underwent PD at the Liver Unit, Queen Elizabeth Hospital.
Six consultant surgeons (J.B., A.D.M., D.F.M., S.B., J.I. and P.M.)
with significant experience in pancreatic resections performed or
supervised all PD. Patients with multi-visceral pancreatic resec-
tions and distal pancreatectomies were excluded from the present
study. The data on pre- per- and post-operative parameters were
collected prospectively and maintained on a secure pancreatic
database by a full-time database manager. The following data were
collected on the database: patient’s demographics, presenting
symptoms, past medical history, pre-operative radiology and
laboratory results, and pre-operative interventions such as
endoscopic retrograde cholangio-panctreaticography (ERCP)/
percutaneous transhepatic cholangiography (PTC), the details of
surgery, post-operative morbidity and mortality, details of all the
post-operative interventions, the cause of death and the histology.
Per- and post-operative management
The institution has a pancreaticoduodenectomy care pathway in
place and this was used to standardize care to ensure uniform
post-operative management. All patients were given prophylactic
antibiotics (as per the local antibiotic guidelines) at the time of
induction and antibiotics were continued for 24 h after surgery.
Prophylactic octreotide (100 mg subcutaneously three times a day)
was routinely given to all patients for 5 days. All patients had
nasogastric (NG) and nasojejunal (NJ) tubes placed at the time of
surgery and were started on enteral feed via a nasal gastric tube on
the first post-operative day at 10 ml/hour and increased to 30 ml/
hour on day three and the feed continued until day 6 and for
longer if necessary. Abdominal drain volumes were measured
every 24 h and drain fluid amylase (DFA) levels were measured on
day 5. The timing of the drain removal was left to the individual
surgeon’s discretion. On average, the drain was removed on day
six but they were left in for longer if the DFA was more than three
times the serum levels, or if the contents were bilious, enteric,
milky, water or ‘prune juice’ in appearance. Once the surgeon was
satisfied that there was no evidence of PF, bile leak or enteric leak
the NG and NJ tubes were removed on day six and patients were
allowed to have clear fluids and gradually built up to normal diet
over next 48 h. Where appropriate, patients with PF were also
treated with antibiotics, total parental nutrition (TPN), prolonged
drainage, radiological procedures or surgery as appropriate.
Surgical technique
The pancreatic reconstruction was performed using either a PG or
PJ reconstruction technique depending on the individual sur-
geon’s choice. The techniques of PJ reconstruction were: the end-
to-end dunking technique or two-layered duct-to-mucosa
anastomosis. For both techniques, a 1.5- to 2-cm cut end of
remnant of the pancreas was mobilized from the splenic vein. The
proximal end of the retained jejunum is brought through a right
transverse mesocolic window. The end-to-end pancreaticojejun-
ostomy was created by invaginating the end of the pancreatic
remnant into the end of the jejunum using a single-layer, continu-
ous 3–0 Polypropylene (Prolene) suture (Ethicon, Johnson &
Johnson, UK). The two-layered duct-to mucosa PJ reconstruction
was created by interrupted 4–0 Poly dioxone (PDS, Ethicon,
Johnson & Johnson, UK) for the duct to-mucosa anastomosis and
3–0 PDS for the parenchymal suturing as previously described by
Z’graggen et al. in 2002.22
The pancreaticogastrostomy was carried out under direct
vision through an anterior gastrostomy. First, a 4–5 cm stump of
the pancreas was mobilized from the splenic vessels and retroperi-
toneum. The stump of the pancreatic remnant brought out
through an oblique incision in the posterior wall of the mid-body
of the stomach and sutured to the posterior wall of the stomach
with continuous 3–0 Prolene ensuring that the pancreatic duct
lumen is not obliterated. An anterior wall gastrostomy is closed
with a continuous 3–0 PDS suture at the end of the procedure.
After completion of a pancreatic reconstruction a retro-colic
hepatico-jejunostomy was performed with a continuous 4–0 or
5–0 double-ended PDS suture as previously described.23 This was
followed by a single-layer, end-to-side duodeno-jejunostomy (DJ)
or gastrojejunostomy (GJ) with a continuous 3–0 PDS suture
approximately 40–50 cm from the biliary anastomosis. The NJ
and NG tubes were placed into the efferent jejunal loop and
stomach, respectively, before the closure of the anterior layer of
the DJ/GJ anastomosis. A 32-F Robinson’s portex drain® was
placed posterior to the pancreatic and biliary anastomosis and
brought out through the lateral abdominal wall on the right-hand
side and secured with a 1–0 silk suture and connected to a closed
non-vacuum drainage system.
Pancreatic fistula and other complications
A PF was classified into three grades based on ISGPF criteria.21
The full details of the classification are summarized in Table 1.
The definitions of various other complications are described in
Table 2. PF was defined as drain output of any measurable volume
of fluid on or after post-operative day 3 with amylase content
greater than three times the serum amylase activity. This defini-
tion also includes all peri-pancreatic collections, abscesses, leaks
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and fistulae thought to manifest from poor anastomotic healing.
PF has been classified into three grades: A, B and C.21
Statistical analysis
Statistical analysis was performed using Statistical Package for
Social Sciences (SPPS, Inc., Chicago, IL, USA) version 16. Quali-
tative data were compared using a c2-test with Yates’ correction or
a Fisher’s exact test when necessary. Normally distributed data are
presented as mean  standard deviation (SD) and other data
presented as median and range. The independent t-test was
employed to compare the means of the two normally distributed
groups. Non-parametric tests were employed to examine the dif-
ference between the two samples when the data had a highly
skewed distribution. All P-values were two-tailed, and the P < 0.05
was considered to indicate statistical significance.
Results
Overall group
Between January 2005 and December 2009, 424 patients under-
went (pylorus-preserving PD (PPPD) = 385; Kausch–Whipple’s
PD (KWPD) = 39) a pancreaticoduodenectomy. One hundred
and seventy patients (40.0%) had post-operative complications.
The overall PF rate was 20.0% (85 patients): grade A in 24 (5.6%),
B in 34 (8.0%) and grade C in 27 (6.3%) patients. Seventeen
patients (4.0%) had an enteric leak, and in 13 of these the leak was
associated with PF (grade B = 5 & C = 8). Seven out of 17 patients
Table 1 The ISGPF criteria used for grading of the pancretic fistula (Adapted with permission from Bassi C, Dervenis C, Butturini G et al.
Post-operative pancreatic fistula: an international study group (ISGPF) definition21
Criteria No fistula Grade A fistula Grade B fistula Grade C fistula
Drain amylase <3x normal
serum amylase
>3x normal
serum amylase
>3x normal
serum amylase
>3x normal
serum amylase
Clinical conditions well Well often well ill appearing/bad
Specific treatment No No Yes/No Yes
US/CT (if obtained) Negative Negative Negative/Positive Positive
Persistent drainage > 3 weeks No No Usually Yes Yes
Signs of infection No No Yes Yes
Readmission No No Yes/No Yes/No
Sepsis No No No Yes
Re-operation No No No Yes
Death related to fistula No No No Yes
US, ultrasound; CT, computer tomogram
Table 2 The definitions of various complications
Complication Definition
Wound infection Any evidence of infection (i.e. erythaema, purulent discharge, induration) requiring antibiotic treatment, or
evidence of dehiscence
Post pancreatectomy
haemorrhage
Haematemesis or melena and no other source of ongoing blood loss, or the sudden appearance of frank
blood either in the NG tube or per rectum, with subsequent fall in haemoglobin of 2 g/dl, and requiring
blood transfusion or reoperation or radiological intervention or endoscopic intervention)
Delayed gastric emptying Failure to resume oral liquid intake by post-operative day 10, and/or emesis > 500 ml on or after
post-operative day 5, and/or continued nasogastric drainage > 500 ml on after post-operative day 5
Acute renal failure Serum creatinine doubling of baseline value, and/or need for dialysis
Acute respiratory failure Respiratory distress requiring intubation, or the need for intubation or mechanical ventilation for more than
24 h post-operatively
Enteric leak Leakage of enteric contents from intra-operatively placed drains, and/or radiographically confirmed fluid
collection, requiring surgical, endoscopic, or radiographic intervention
Bile leak Bilious drainage from intra-operatively placed drains, and/or radiographically confirmed fluid collection,
requiring surgical, endoscopic, or radiographical intervention
Chest infection Presence of body temperature > 38°C, abnormal elevation of white blood count, or positive sputum Gram
stain or culture along with presence of clinical or radiological signs of chest infection and requiring intra
venous or oral antibiotic treatment
90-day mortality Death during the initial hospitalization or within 90-days of hospital discharge
Hospital stay The number of days in hospital from the time of initial operation to hospital discharge
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underwent a re-laparotomy for a leak from DJ (n = 5), leak from
PJ (n = 1) and leak from both PJ and DJ anastomosis (n = 1).A bile
leak occurred in eight patients and all of them except one were
managed conservatively. In total, 18 (4.2%) patients required a
re-laparotomy for various indications and 31 (7.3%) patients
required radiological intervention. The median hospital stay was
10 days (range: 7–141). The median hospital stay was 21 days
(7–141) in the PF group compared with 9 days (range: 7–60, P =
0.001) in the non-fistula group. The 90-day mortality was 7.8%
(33 patients). The main causes of death were sepsis with multi-
organ failure in 15 (3.5%), bleeding in 9 (2.1%), respiratory
failure in 3 (0.7%) and other causes in 6 (1.4%) patients. Sixteen
(57.1%) out of 28 patients with a post-pancreatectomy haemor-
rhage (PPH) died within 90-days. Eight (2.5%) out of 323 patients
with no PF and PPH died within 90 days compared with 10 out of
13 (76.9%) (P = 0.001) with a PF and PPH.Nine (12.3%) out of 73
patients with a PF and no PPH died within 90 days compared with
six (40.0%) out of 15 patients (P = 0.001) with a PPH alone.
PG and PJ groups
A pancreaticogastrostomy was performed in 239 (56.4%) and a PJ
was performed in 185 (43.6%) patients. In the PJ group, 128
(69.2%) had end-to-end dunking type reconstruction and 57
(30.8%) had two-layered duct-to-mucosa reconstruction. Patient
demographics, pre-operative, operative, post-operative and histo-
logical details of both groups are summarized in Table 3. Two
groups were similar with respect to age, pre-operative biliary
drainage, site and size of the tumour, indication and type of resec-
tion. However, there were significantly more male patients in the
PJ group.
Pancreatic fistulae
Pancreatic fistulae occurred in 55 (23.5%) in the PG and 30
(16.2%, P = 0.067) patients in the PJ group.A grade A PF occurred
in 19 (7.9%), B in 22 (9.2%) and C in 14 (5.8%) in the PG group
compared with a grade A in 5 (2.7%), B in 12 (6.5%) and C in 13
Table 3 Patient characteristics, pre-operative, per-operative and post-operative parameters of patients in the PG and PJ groups
Varaibles Panctreatico-gastrostomy (%) Panctreatico-jejunostomy (%) P-value
Number of patients 239 (56.4) 185 (43.4)
Age in years (median and range) 65.7 (17–83) 65.8 (32–83) 0.839
Gender, n
Female 121 (50.6) 69 (37.6) 0.006
Male 118 (50.4) 116 (62.4)
Pre-operative biliary drainage, n 100 84 0.452
Indication for resection, N
Benign lesions 26 27 0.515
Malignant tumours 204 (85.4) 151 (81.6)
Neuroendocrine tumours 9 7
Type of PD, n
Classic PD 18 21 0.181
PPPD 221 (92.5) 164 (88.6)
Portal vein resection, n 27 21 0.866
Site of the lesion, n
Ampullary 57 48 0.483
Head of pancreas 138 (57.7%) 99 (53.5%)
Distal bile duct 24 26
Duodenum 13 5
Others 7 7
Size of the tumour, median 3 cm (0.5 to 17) 3 cm (0.9 to 11) 0.414
Hospital stay (median and range), days 10 (7–141) 10 (7–77) 0.199
Overall pancreatic fistula rate, n 55 (23.4) 30 (16.2) 0.067
Grade of pancreatic fistula, n
Grade A 19 (7.9%) 5 (2.7%) 0.019
Grade B 22 (9.2%) 12 (6.5%) 0.368
Grade C 14 (5.8%) 13 (7%) 0.690
PD, pancreaticoduodenectomy; PPPD, pylorus preserving pancreaticoduodenectomy
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(7.0%) in the PJ group. There was no significant difference in the
overall PF rate between the two sub-groups of PJ reconstruction
methods.
Grade A fistulae
A total of 19 (7.9%) in the PG group had a PF compared with 5
(2.7%) patients in the PJ group (7.9 vs. 2.7%, P = 0.019). The
median hospital stay was 12 days (range: 7–40) in the PG and 13
(range: 10–37) days in the PJ group (P = 0.239). Three patients
in the PG and two patients in the PJ group had a computed
tomography of the abdomen (CTA) for the investigation of
pyrexia associated with raised inflammatory markers. The CTA
did not show any evidence of intra-abdominal collection
(IABC) in all patients. Three patients in the PG and one patient
in the PJ group required antibiotics for a chest and wound
infection, respectively. The 90-day mortality was zero in both
groups.
Grade B fistulae
Grade B fistulae occurred in 22 (9.2%) in the PG and 12 (6.5%)
patients in the PJ group (9.2 vs. 6.5%, P = 0.368). The details of
investigations, further complications and the management of
patients with grade B fistula are summarized in Table 4. The
median (range) hospital stay was 21.5 (8–43) days in the PG and
23 (13–50) days in the PJ group (P = 0.631). Eighteen in the PG
and nine patients in the PJ group had signs of infection (P =
0.676). Nine in the PG and three patients in the PJ group had
IABC. There were no mortalities in both groups.
Grade C fistulae
Grade C fistulae occurred in 14 (5.8%) in the PG and 13 (7.0%)
patients in the PJ group (5.8 vs. 7.0%, P = 0.690). The median
(range) hospital stay was 35.5 days (8–141) in the PG compared
with 28 days (10–77, P = 0.458) in the PJ group. Twelve in the PG
and nine patients (P = 0.385) in the PJ group had signs of infec-
tion. The details of investigations, re-operations and other com-
plications are summarized in Table 5.
Table 4 The details of further investigations and findings and treat-
ment of patients with grade B fistula
Variables PG, n = 22 PJ, n = 12 P-value
Investigations, n 19 7 0.270
CT 17 7
US 2 0
Radiology findings, n
Free fluid 1 1
Liver abscess 1 0
Intra abdominal collection 9 3 0.537
Signs of infection, n 18 9 0.676
Treatment, n
Radiological drainage 5 3
Antibiotics 17 9
Drain left longer 3 4
Total parental nutrition 10 8
Re-operation None None
Other complications, n
Enteric leak 4 1 0.635
Bile leak 1 2 0.279
Chest infection 4 4 0.410
Wound infection 2 2 0.602
90-day mortality 0 0
Median (range) hospital
stay, days
21.5 (8–43) 23 (13–50) 0.631
CT, computer tomogram; US, ultrasound
Table 5 The details of further investigations and findings,
and treatment of patients with a grade C fistula
Variables PG, n = 14 PJ, n = 13 P-value
Investigations (CT), n 10 10 1.000
CT findings
Free fluid 0 1
IABC 8 5
Anastomotic leak 0 1
No collection 2 3
Sepsis 12 9 0.385
Treatment
Radiological drainage 7 4
Surgery 5 6 0.285
Total pancreatectomy 2 1
DJ repair 2 2
PPH control 1 3
TPN 7 8
Other complications
Enteric leak 3 3 1.000
Bile leak 2 1 1.000
Chest infection 4 2 0.648
Wound infection 3 0 0.222
PPH 4 9 0.057
Source of bleed
Cut surface of pancreas 2 5
Unknown source 1 1
DJ anastomosis 1 0
Pseudoaneurysms 0 3
90-day mortality 9 10 0.677
Hospital stay (median
and range) in days
35.5 (8–141) 28 (10–77) 0.458
CT, computer tomogram; IABC, intra abdominal collection; DJ, duode-
nojejunal; PPH, post pancreatectomy haemorrhage; TPN, total parenteral
nutrition
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Overall morbidity and mortality between the PG and
PJ groups
The details of other complications between the PG and PJ groups
are summarized in Table 6. There was no significant difference in
the rate of PPH, delayed gastric emptying (DGE), enteric leak, bile
leak, chest and wound infection, renal failure, respiratory failure,
arrhythmias, sepsis and IABC between both groups. The overall
complication rate (including the patients who had PF) was higher
in the PG (108, 45.2%) compared with the PJ group (62, 33.5%, P
= 0.017). However, after excluding patients with PF that was not
associated any other complications, there was no significant dif-
ference in the morbidity between both groups (88, 36.8% in PG
vs. 58, 31.4% in PJ, P = 0.258). A total of 18 patients required a
re-laparotomy, and re-laparotomy rates were similar between both
groups: 4.2% (n = 10) in the PG vs. 4.3% (n = 8) (P = 1.000) in the
PJ group. There was no significant difference in the 90-day mor-
tality between both groups (17, 7.1% vs. 16, 8.6%, P = 0.558).
However, the 90-day mortality after PPH was significantly higher
in the PJ group (71.4%, 10 out of 14) compared with the PG group
(42.8%, 6 out of 14 patients, P = 0.001).
Discussion
The main cause of post-operative morbidity and mortality after
PD is a pancreatic fistula. Before to July 2005, there was no uni-
versally accepted definition of PF and the diagnosis of PF was
mainly based on the presence of amylase-rich drain fluid (three
times the normal serum activity). However, not all biochemical
fistulae were clinically significant and defining the presence or
absence of a fistula based on the DFA and drain volume can alone
underestimate a clinically significant fistula. In July 2005, the
International Study Group for Pancreatic Fistula (ISGPF) devel-
oped a universal definition of PF and classified PF into three
grades based on clinical parameters.21 After the publication of the
ISGPF classification, Pratt et al. studied the incidence of PF in 176
consecutive patients who underwent PD and observed an inci-
dence of 30%, much higher than many of the previously pub-
lished studies.24 Themajority of patients developed grade A (15%)
and grade B (12%) fistulae. Grade C fistulae only occurred in 3%
of cases. However, when they re-classified PF based on five previ-
ously used PF definitions, they noted wide variations in the inci-
dence of PF (9% to 19%).24 Fuks et al. studied the incidence of PF
in 680 patients from five centres in France and observed an overall
PF rate of 16.3%. The grade C fistula was observed in 5.6% of
patients.25
As a part of the meta-analysis, Wente et al. performed a pooled
analysis of 12 observation studies (published before the introduc-
tion of ISGPF classification), and found a PF rate of 3.7% in the
PG group compared with 16.5% (P = 0.001) in the PJ group. There
was no significant difference in the overall hospital stay between
both groups.26 The overall mortality rate was 3.0% in the PG
group compared with 9.1% (P = 0.001) in the PJ group. As part of
the same study, Wente et al. also performed a pooled analysis of
three randomized controlled trials (published before the intro-
duction of ISGPF classification), and found no difference in the
incidence of PF (13.9% vs. 15.8%, P = 0.54), DGE (12.7 vs. 16.9%,
P = 0.54) and bile leak (3.1 vs. 5.4%, P = 0.53) between the PG and
PJ groups. The length of stay was shorter in the PG group, after
excluding the results from the French series.26
In the current series, the ISGPF classification scheme was
applied retrospectively to study the rate and the severity of PF in
patients who underwent PG and PJ reconstruction methods after
PD. This is the first major study that applied the ISGPF criteria to
compare the PF rate between two of most commonly used recon-
Table 6 The details of other complications and overall morbidity and mortality between the PG and PJ groups
Variables PG, n = 239 (%) PJ, n = 185 (%) P-value
Other complications
PPH 14 (5.9) 14 (7.6) 0.556
Chest infection 26 (11) 18 (9.7) 0.750
Respiratory failure 21(8.8) 9 (5) 0.130
Wound infection 17 (7) 11 (6) 0.696
Enteric leak 12 (5) 5 (2.7) 0.319
Bile leak 5 (2.3) 3 (1.6) 1.000
Renal failure 8 (3.3) 10 (5.4) 0.573
Delayed gastric emptying 2 (0.8) 5 (2.7) 0.248
AF 12 (5) 9 (5) 1.000
Re-laparotomy 10 (4.2) 8 (4.3) 1.000
Others 6 (0.2) 5 (2.7) 0.685
Overall morbidity, n 108 (45.2) 62 (33.5) 0.017
Overall morbidity after excluding patients with PF alone 88 (36.8) 58 (31.4) 0.258
90-day mortality 17 (7.1) 16 (8.6) 0.558
PPH, post pancreatectomy haemorrhage; AF, atrial fibrillation; PF, pancreatic fistula
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struction techniques. The overall fistula rate of 20% was similar to
many published series.1,3,4,25,26 The grade C PF rate of 6.4% in the
current series was also similar to many published series.24,25 The
overall PF rate was higher in the PG group because of a higher
incidence of grade A fistulae. However, more patients in the PJ
group had clinically significant (not statistically significant) pan-
creatic fistulae, supporting the findings of previously published
observational studies.26 There was no difference in the overall PF
rate and grade of PF between two sub-types of PJ reconstruction.
The higher rate of a grade A PF in the PG group suggest that
although the risk of a biochemical fistula is higher in PG the
clinical consequences are less severe compared with the pancreatic
leak after PJ reconstruction. This could be because of several
reasons: inhibition of pancreatic enzyme activation by acid envi-
ronment, an absence of enterokinase in the stomach (necessary
for activation of trypsinogen),27 a thick-walled stomach with an
excellent blood supply,17 prevention of marginal ulceration by
neutralization of acid by pancreatic juices, decompression of the
stomach by the nasal gastric tube preventing stasis of gastric and
pancreatic contents, and the absence of the long jejunal loop with
the accumulation of biliary and pancreatic contents.17
Similar to the previously published studies,26 the hospital stay
was shorter in the PG group compared with the PJ group. The
hospital stay was significantly longer in the PF group compared
with the non-fistula group. However, subgroup analysis showed
that the length of hospital stay was shorter in the PJ compared
with the PG group in patients with a grade C PF. This could be as
a result of the fact that more patients in the PJ group with a grade
C PF had a higher early hospital mortality. The overall morbidity
was significantly higher in the PG group when all post-operative
complications including the PF were included. However, when
patients with a grade A PF that were not associated with any other
complications were excluded the morbidity was similar between
both groups.
The overall mortality in the current series was much higher
compared with the randomized Italian4 and John Hopkin’s
series3,4,28 and similar to the French1 and many observational
studies.13–18,29 The 90-day mortality rate was zero among patients
with grade A & B compared with 70% (19 out of 27) in patients
with a grade C leak. There was no significant difference between
the PG and PJ groups and among the two different sub-types of PJ
reconstruction supporting the notion that it is the experience and
familiarity of the surgeon with one particular pancreatic recon-
struction technique that is the most important factor in reducing
the PF rate and not the type of reconstruction.30–32
The high mortality among patients with a grade C PF is as a
result of a high incidence of associated intra-abdominal abscesses,
bleeding and sepsis. In a large retrospective series by Fuks et al., 35
out of 36 patients with a grade C PF required re-operation for
either a pancreatic leak or intra-abdominal haemorrhage.25 In the
current series, the 6.6% prevalence of a PPH was similar to 5–12%
prevalence reported in the literature.33–36 In a large retrospective
series, Yekebas et al. found 5.7% prevalence of PPH and in 39% of
patients a PPHwas associated with PF. They also observed that the
PPH–related mortality was closely associated with the occurrence
of PF, vascular pathologies, and soft pancreas texture.33 In the
present study, PPH was associated with a grade C PF in 46% of
patients but none of the patients with a grade A and B PF had
PPH. Furthermore, the prevalence of PPHwas significantly higher
among patients with a grade C PF after PJ reconstruction. The
90-day mortality in patients with a PPH associated with a PF was
77% compared with 40% in patients with a PPH but with no PF
(P = 0.001). The higher prevalence of PPH and associated mor-
tality among grade C patients in the PJ group could be because of
erosion of the major blood vessels and the surrounding tissue by
the activated pancreatic enzymes and high volume pancreatic
juice. This is less of a problem in patients with PG reconstruction
as the stomach is decompressed by the nasogastric tube and
trypsinogen is not activated by the gastric juice. Another reason
for the high mortality among patients with a grade C PF in this
series could be because of inclusion of late mortalities that
occurred after patients were discharged from the hospital. Our
approach for management of grade C fistulae includes urgent
laparotomy for patients who have an acute abdomen or are
unstable from severe bleeding. For stable patients our approach is
one of radiological drainage for collections escalating to surgical
intervention if there is no improvement. For bleeding an attempt
at radiological stenting or embolization is tried and if this fails a
laparotomy is carried out. Overall, 11 (40.3%) out of 27 patients
with a grade C leak underwent a re-laparotomy but only three had
a completion pancreatectomy. The rest had an attempt to control
the leak or haemorrhage. The majority with a grade C leak were
managed radiological or medically but did not reach a laparotomy
– either they were judged to be responding or were too ill for a
major intervention. As the mortality of our group of grade C leak
patients was higher than some published series it could be postu-
lated that a more aggressive approach with more patients having
earlier surgical intervention, and more use of completion pancre-
atectomy in the surgical group, could have improved the outcome.
The major criticism of the present study would be the retro-
spective nature of the study. It has all the disadvantages that are
associated with any retrospective series. However, patients in both
groups were well matched for every parameter except the gender
ratio. Furthermore, this should not influence either the incidence
of PF or any other complications between both groups. There
were no data on the consistency of the pancreas and the pancreatic
ductal diameter but there was no reason to believe that there were
more patients in either group with a soft pancreas as the number
of patients who underwent pre-operative biliary drainage, indica-
tions and the diagnosis was similar between both groups.
Conclusions
In the current series, the ISGPF classification system has been
successfully applied to a large group of patients who underwent a
PD followed by either PG or PJ reconstruction. The grade PF rate
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was significantly higher in the PG group compared with the PJ
group. There was no significant difference in the overall PF rate,
90-day mortality and length of hospital stay between both
methods supporting the notion that the experience and familiar-
ity of the surgeon with one particular reconstruction technique is
perhaps more important than the type of reconstruction itself.
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